ro 136680 has been researched along with 1-aminoindan-1,5-dicarboxylic acid in 1 studies
| Studies (ro 136680) | Trials (ro 136680) | Recent Studies (post-2010) (ro 136680) | Studies (1-aminoindan-1,5-dicarboxylic acid) | Trials (1-aminoindan-1,5-dicarboxylic acid) | Recent Studies (post-2010) (1-aminoindan-1,5-dicarboxylic acid) |
|---|---|---|---|---|---|
| 5 | 0 | 1 | 110 | 0 | 16 |
| Protein | Taxonomy | ro 136680 (IC50) | 1-aminoindan-1,5-dicarboxylic acid (IC50) |
|---|---|---|---|
| Metabotropic glutamate receptor 1 | Homo sapiens (human) | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, K; Shirane, M | 1 |
1 other study(ies) available for ro 136680 and 1-aminoindan-1,5-dicarboxylic acid
| Article | Year |
|---|---|
Group II metabotropic glutamate receptors are a common target of N-anisoyl-GABA and 1S,3R-ACPD in enhancing ACh release in the prefrontal cortex of freely moving SHRSP.
Topics: Acetylcholine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amino Acids, Dicarboxylic; Animals; Anisoles; Benzoates; Cycloleucine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glycine; Hippocampus; Indans; Male; Microdialysis; Perfusion; Prefrontal Cortex; Quinoxalines; Rats; Rats, Inbred SHR; Receptors, AMPA; Receptors, Metabotropic Glutamate; Thalamic Nuclei; Wakefulness | 2000 |